Erythromycin-resistant Streptococcus pneumoniae isolates from young carriers were tested for their antimicrobial susceptibility; additionally, inducibility of macrolide and clindamycin resistance was investigated in pneumococci carrying erm(A), erm(B), or mef(A). Of 125 strains tested, 101 (81%) were multidrug resistant. Different levels of induction were observed with erythromycin, miocamycin, and clindamycin in erm(B) strains; however, in erm(A) strains only erythromycin was an inducer. Induction did not affect macrolide MICs in mef(A) strains.
The predominant mechanisms of resistance to erythromycin and the other macrolides in Streptococcus pneumoniae are through target site modification by methylation that prevents the binding of the antibiotic to its ribosomal target, encoded by the erm(B) gene (16) , or through efflux of the antibiotic, mediated by the mef(A) gene (13) . Methylation of the ribosomal target of the antibiotics leads to cross-resistance to macrolides (M), lincosamides (L), and streptogramin B (S B ), the so-called MLS B phenotype. Erm methylase synthesis can be inducible or constitutive (10, 11) . Alterations in ribosomal proteins L4 and L22 or 23S rRNA have been reported to cause resistance in S. pneumoniae (1) . Antibiotic efflux confers resistance only to the 14-and 15-member macrolides (1, 4, 5, 7) .
Recently, S. pneumoniae isolates resistant to erythromycin due to carriage of the erm(A) gene have been reported (15) . The macrolide resistance determinant erm(A) gene was previously described as erm(TR) in S. pyogenes (12) and now is reclassified as erm(A) (9) .
The present study was undertaken to compare differences in antimicrobial susceptibility between S. pneumoniae isolates harboring erm(A) and those carrying either the erm(B) or mef(A) gene and to investigate the effect of induction on the expression of macrolide resistance in erm(A)-, erm(B)-, or mef(A)-positive pneumococci. The presence of genes coding for macrolide resistance was studied by PCR as described previously (8, 12, 13 (14, 15) , were evaluated for their susceptibility to 10 antibiotics representing different classes of antimicrobial agents. These agents were 14-member (erythromycin and clarithromycin), 15-member (azithromycin), and 16-member ring macrolides (miocamycin), lincosamides (clindamycin), streptogramins (quinupristin/dalfopristin), ketolides (telithromycin), penicillin G, tetracycline, and chloramphenicol. Antimicrobial susceptibility tests were performed by the agar dilution method as previously described (3) . Plates were incubated in ambient air at 37°C. Antibiotics were obtained from their respective manufacturers. Miocamycin was from Meiji Seika Kaisha (Tokyo, Japan). Except for those of miocamycin and telithromycin, MICs were interpreted according to the criteria of the National Committee for Clinical Laboratory Standards (NCCLS) (6) . European breakpoints were used for miocamycin (Յ1 g/ml) (2) and telithromycin (Յ0.5 g/ml) (C. The effect of induction by erythromycin, miocamycin, or clindamycin on the expression of resistance to erythromycin, clarithromycin, azithromycin, miocamycin, clindamycin, and telithromycin was evaluated. For induction studies, strains were incubated overnight on separate blood agar plates containing no antibiotic, 0.05 g of erythromycin/ml, 0.05 g of miocamycin/ml, or 0.01 g of clindamycin/ml. MIC agar plates contained the same concentration of inducer to continue the effect of induction in addition to the concentration of antibiotic tested, except for MIC testing of the inducer. The concentration of antibiotic for induction was 1/5 to 1/10 of the lowest MIC level for a given antibiotic. The four erm(A), five erm(B), and two mef(A) pneumococci were tested for inducibility of resistance. All strains studied for induction were tested for the presence of mutation in the fifth domain of 23S rRNA and ribosomal proteins L4 and L22 as described previously (1) . Only one strain with mef(A) had a mutation in L22 (K94R). In the macrolide MICs no significant differences were observed between the mef(A) strain with a mutation in a highly conserved region of L22 and other strains without any mutation.
Of the 125 erythromycin-resistant pneumococci, 4 (3%), 84 (67%), and 37 (30%) isolates harbored the erm(A), erm(B), or mef(A) gene coding for macrolide resistance, respectively. None of the S. pneumoniae isolates was found to carry more than one macrolide resistance gene.
Of 125 erythromycin-resistant strains, 101 (81%) were also intermediate or resistant to one or more classes of antimicrobial agents other than macrolides and lincosamides. The four erm(A) pneumococci had decreased susceptibility to tetracycline; one isolate was intermediate and three were resistant ( Table 1) . Of the 84 erm(B) isolates, 78 were also resistant to tetracycline, 68 were resistant to chloramphenicol, and 39 were intermediate or resistant to penicillin. Of the 37 mef(A) pneumococci, 16 were also intermediate or resistant to penicillin, 14 were resistant to tetracycline, and 1 was resistant to chloramphenicol.
The susceptibilities to 14-, 15-, and 16-member macrolides and clindamycin of the pneumococcal isolates carrying an erm(A), erm(B), or mef(A) gene, appear in Table 1 . Macrolide and clindamycin resistance levels were high in S. pneumoniae with the erm(B) gene but were low in the strains with erm(A) or mef(A). Two of the S. pneumoniae strains were not resistant to clindamycin despite having an erm(B) gene. The MICs of clindamycin were 0.25 and 0.5 g/ml for these strains, and the MIC of miocamycin was 1 g/ml. The MICs of erythromycin, clarithromycin, and azithromycin (Ͼ64 g/ml) were high for these strains. Among pneumococci that harbored erm(B), 5 (6%) and 1 (1.2%) were susceptible and 16 (19%) and 1 (1.2%) were intermediate to miocamycin and clindamycin, respectively. Among pneumococci that harbored mef(A), 0, 1 (3%), and 1 (3%) were susceptible and 1 (3%), 7 (19%), and 4 (11%) were intermediate to erythromycin, clarithromycin, and azithromycin, respectively. All strains tested were susceptible to telithromycin at Յ0.5 g/ml, regardless of their macrolide resistance mechanism.
The results of inducibility studies are summarized in Table 2 . In erm(A) strains, induction with clindamycin or miocamycin did not affect MICs for the antimicrobials tested. Induction with erythromycin did not significantly increase the MICs of erythromycin, clarithromycin, azithromycin, or telithromycin; after induction, MICs did not increase or increased a maximum of fourfold for these antibiotics. However, erythromycin induction caused a very high level of increase, at least 512-fold, in clindamycin MICs. For strains with erm(A), erythromycin was the only inducer, and the erythromycin induction was especially increased in clindamycin MICs.
Among the five S. pneumoniae isolates carrying an erm(B) gene that were tested, two already had high-level resistance (Ͼ64 g/ml) to erythromycin, clarithromycin, and azithromycin. In these strains induction with erythromycin increased the MICs for miocamycin and clindamycin 8-to 16-fold and 4-to more than 128-fold, respectively. Clindamycin induction increased the MICs for miocamycin and clindamycin to 8 and 32 to 64 g/ml regardless of the initial MICs. Induction with miocamycin did not significantly affect the level of resistance for miocamycin among 2 erm(B) strains with high-level erythromycin resistance. Miocamycin induction increased the MIC of clindamycin for erm(B) strain 129. For the three erm(B) strains The results of the present study indicate that the ability of erythromycin, miocamycin, and clindamycin to induce resistance was different in erm(A)-or erm(B)-carrying S. pneumoniae isolates. Macrolide and clindamycin resistances were found to be inducible by erythromycin, miocamycin, and clindamycin in erm(B) strains. By contrast, in S. pneumoniae isolates with the erm(A) gene, erythromycin was the only inducer and clindamycin MICs were most influenced by erythromycin induction. The high level of resistance to clindamycin in induced erm(A) pneumococci may show that methylation by erm(A)-encoded methylases affect clindamycin susceptibility more than macrolide susceptibility. This finding is in contrast with the MICs of drugs obtained for strains with methylated adenine at position 2058 of 23S rRNA. Methylation or base substitution at position 2058 of 23S rRNA affects mainly 14-and 15-member macrolides, and substitution of this base moderately increases the level of MICs for clindamycin (1) . The affect of erm(A)-encoded methylase seems to be different from that of the other erm-encoded methylases that methylate adenine at position 2058. In erm(B) strains, erythromycin, clindamycin, and miocamycin appeared to be inducers of resistance. Erythromycin is the most potent inducer, followed by clindamycin and miocamycin. Miocamycin induced its resistance significantly in only two strains with erm(B). Clindamycin induction, regardless of the initial MIC, increased the level of clindamycin resistance to a certain level (32 to 64 g/ml). Occasionally erm(B) isolates appeared to be resistant to 14-and 15-member macrolides and susceptible or intermediate to 16 -member macrolides and/or to clindamycin according to the applied criteria (2, 6) . Especially in erm(B) strains, the ability of macrolides and clindamycin to induce their resistance should be taken into consideration when choosing antibiotics for treatment. Telithromycin can be distinguished from the other antibiotics tested: the constitutive or inducible expression of erm-type resistance or induction by erythromycin, clindamycin, or miocamycin did not change the activity of telithromycin on the S. pneumoniae strains tested.
